A transgenic construct containing 381 bp of coding sequence of the human T-cell leukemia/lymphoma 1 gene (TCL1A) under the control of the mouse CD79B antigen ( Cd79b) minimal promoter was injected into fertilized (C57BL/6 x C3H)F1 mouse eggs. Founder line BK was established.